[Is digitalis currently useful for heart failure treatment?].
نویسنده
چکیده
Después del estudio DIG publicado en 19971 se ha observado un franco declive en el uso de la digital para el tratamiento de la insuficiencia cardiaca; más aún cuando han emergido nuevos medicamentos que han demostrado su utilidad en estos pacientes, especialmente porque reducen significativamente la mortalidad, y es por ello que viene a la mente que un fármaco tan antiguo como la digital está realmente obsoleto en nuestro tiempo; sin embargo, para poder concluir esta aseveración, como lo han hecho un gran número de cardiólogos, especialmente de las nuevas generaciones, valdría la pena reflexionar si efectivamente este viejo fármaco no tiene cabida en el manejo medico actual de la insuficiencia cardiaca, por lo que es conveniente revisar si existe evidencia de su utilidad al analizar los estudios más importantes que se hicieron a lo largo del siglo xx para conocer sus propiedades terapéuticas, que pudiera justificar su uso en nuestro tiempo. Como sabemos, la digital se ha usado durante más de 200 años para el tratamiento de este mal, pero obviamente no existían otros fármacos, además de los diuréticos, que pudieran tener acciones que justificaran su utilización; en 1920 el Maestro Ignacio Chávez realiza su tesis recepcional sobre la digital, y de ella se destacan 2 conceptos fundamentales que están vigentes hasta la fecha. En primer lugar, el Maestro menciona que este fármaco es útil para tratar «la
منابع مشابه
The contemporary use of digoxin for the treatment of heart failure.
The use of digitalis has been plagued by controversy since its initial use by Withering in 1775. We now have much more data,1 but it should be remembered that the Digitalis Investigator Group trial was executed when -blockers were not widely used to treat heart failure. There are still many questions about where we currently stand with the use of digitalis. Specifically, when should one add dig...
متن کاملشناسایی گلیکوزیدهای قلبی گونه دیژیتال ایران به روش HPLC
Background and Purpose: Digitalis species and their cardiac glycosides are used in congestive heart failure (ÇHF) disease. Digitalis nervosa are grown only in the North regions of Ïran. Çardiac glycosides of other species are identified by HPLÇ procedure. Ïn this research, cardiac glycosides of Digitalis nervosa were identified. Materials and Methods: Ïn this research, methanol as solvent ...
متن کاملHow to select a drug for the long-term treatment of chronic heart failure.
First-line drugs for the treatment of chronic congestive heart failure should produce immediate symptomatic benefit, improve exercise tolerance, and thereby improve the quality of life. They should preferentially be active as monotherapy or at least reduce the need for comedication. The drugs must be safe and well tolerated by patients and change, in the end, the natural history of the disease,...
متن کاملDigitalis Therapy in Patients with Congestive Heart Failure
Herbal Medicine, sometimes referred to as Herbalism or Botanical Medicine, is the use of herbs for their therapeutic or medicinal value. An herb is a plant or plant part valued for its medicinal, aromatic or savory qualities. Herb plants produce and contain a variety of chemical substances that act upon the body. The term digitalis or digitalis compounds are all used to refer to the entire grou...
متن کاملClinical Experience with a New Diuretic, Triamterene, in Conjestive Heart Failure.
Triamterene therapy was evaluated in 35 patients with congestive heart failure over a period of two and one-half years. The parameters used were: clinical assessment; daily 24-hour urine sodium, potassium, chloride, and total volume; bi-weekly serum sodium, potassium, chloride, uric acid, and SGOT; hemogram, and BUN.Triamterene is a moderately potent diuretic and natriuretic, with the added des...
متن کاملThe role of digoxin in the treatment of heart failure.
Digoxin and diuretics were once the cornerstones of therapy for patients with chronic heart failure. During the past 2 decades, an increasing number of therapeutic options for the treatment of symptomatic heart failure has emerged. Demonstrated benefit of these therapies has led to parallel growth of practice guidelines and performance measures. As a result, physicians caring for patients with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archivos de cardiologia de Mexico
دوره 84 4 شماره
صفحات -
تاریخ انتشار 2014